Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune memory assessment after infant 11-valent pneumococcal conjugate vaccination using Pneumo 23 challenge
2004-004370-85Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of Pneumo 23 and 11-valent pneumococcal conjugate vaccine in pneumococcal disease (2 arms), sponsored by GSK. Primary endpoint: Post-challenge antibody concentrations to 11 pneumococcal serotypes. Started Dec 2004; status: completed.
02
Drugs
Pneumo 2311-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2004-004370-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004370-85.